Evaxion Biotech A/S

NASDAQ: EVAX · Real-Time Price · USD
2.88
0.02 (0.70%)
At close: Aug 15, 2025, 3:59 PM
2.84
-1.39%
After-hours: Aug 15, 2025, 04:10 PM EDT

Evaxion Biotech A/S Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-10.55M -22.13M -23.17M -24.53M
Depreciation & Amortization
607.02K 615K 571K 344K
Stock-Based Compensation
357K 479K 942K 1.38M
Other Working Capital
-303K -48.7K -2.28M 1.88M
Other Non-Cash Items
-3.06M 2.76M -243K -171K
Deferred Income Tax
-813K -984K -998K -190K
Change in Working Capital
520K 1.56M -2.88M 1.24M
Operating Cash Flow
-12.94M -17.69M -25.77M -21.93M
Capital Expenditures
n/a -87K -292K -1.36M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-3K -6K n/a n/a
Sales Maturities Of Investments
n/a n/a 24.01K 29.95K
Other Investing Acitivies
n/a 133.00 -13 48.00
Investing Cash Flow
-3K -93K -268K -1.33M
Debt Repayment
-1.14M -632K 7.42M -289K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.29M 2.15M n/a -3.76M
Financial Cash Flow
13.13M 10.69M 7.85M 49.8M
Net Cash Flow
369K -7.6M -18.98M 26.33M
Free Cash Flow
-12.94M -17.78M -26.07M -23.29M